• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同C1q - CIC和C3浓度的系统性红斑狼疮(SLE)患者的临床管理

Clinical management of patients with systemic lupus erythematosus (SLE) with different C1q-CIC and C3 concentrations.

作者信息

Karamehic Jasenko, Subasic Djemo, Kasumovic Mersija, Hodzic Harun, Prljaca-Zecevici Lamija, Tufekcic Mersiha, Aganovic-Musinovic Izeta

机构信息

Institute of Clinical immunology-Clinical Centre, University of Sarajevo, Bolnicka 25, 71000 Sarajevo, Bosnia and Herzegovina.

出版信息

Med Arh. 2010;64(2):75-9.

PMID:20514769
Abstract

Over the third of SLE (Systemic Lupus Erythematosus) patients have a high level auto-antibodies-antigen complex that contains some complement proteins, especially C1q as the trigger protein in the classical complement activation pathway. So, the SLE, as an autoimmune disease, is certainly related to disorders caused by activation of complement system, that finally leads to tissue damage. It may also be caused by hereditary deficiency (complement genes mutations). In such case, some components of the complement system might be inactivated. There are mutations that cause disorders in each of three complement system activation pathways (classical, alternative and lectin).The serum samples of SLE patients show the presence of specific autoantibodies for some complement components. Today, for clinical management of SLE patients, determination of level of C1q-CIC and C3 complement component in serum specimens have great diagnostic and therapeutic importance. During the year 2000, we analyzed a numerous serum samples from patients suspected to autoimmune diseases (SLE especially). The samples were collected from several clinics in the Clinical Center of University of Sarajevo, mostly from Clinic of Infectious Diseases, Pediatrics, Internal Medicine and Gastroenterohepatology Clinic. Primary samples went through screening for the presence of ANA using ANA-IFA method and further characterization of ANA positive samples was carried out using IFA-ANA titration, ELISA and nephelometry.

摘要

超过三分之一的系统性红斑狼疮(SLE)患者体内存在高水平的自身抗体 - 抗原复合物,该复合物包含一些补体蛋白,尤其是作为经典补体激活途径触发蛋白的C1q。因此,作为一种自身免疫性疾病,SLE肯定与补体系统激活所导致的紊乱有关,最终会导致组织损伤。它也可能由遗传性缺陷(补体基因突变)引起。在这种情况下,补体系统的一些成分可能会失活。在补体系统的三种激活途径(经典途径、替代途径和凝集素途径)中,每种途径都存在导致紊乱的突变。SLE患者的血清样本显示存在针对某些补体成分的特异性自身抗体。如今,对于SLE患者的临床管理,测定血清标本中C1q - CIC和C3补体成分的水平具有重要的诊断和治疗意义。在2000年期间,我们分析了大量疑似自身免疫性疾病(尤其是SLE)患者的血清样本。这些样本取自萨拉热窝大学临床中心的几家诊所,大部分来自传染病诊所、儿科、内科和胃肠肝病诊所。首先使用ANA - IFA方法对样本进行抗核抗体(ANA)筛查,然后使用IFA - ANA滴定、酶联免疫吸附测定(ELISA)和比浊法对ANA阳性样本进行进一步鉴定。

相似文献

1
Clinical management of patients with systemic lupus erythematosus (SLE) with different C1q-CIC and C3 concentrations.不同C1q - CIC和C3浓度的系统性红斑狼疮(SLE)患者的临床管理
Med Arh. 2010;64(2):75-9.
2
A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.一项关于印度系统性红斑狼疮患者抗甘露糖结合凝集素(anti-MBL)抗体和血清 MBL 水平的研究。
Rheumatol Int. 2013 May;33(5):1193-9. doi: 10.1007/s00296-012-2519-9. Epub 2012 Sep 13.
3
Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.系统性红斑狼疮中抗染色质抗体和抗C1q抗体与其他系统性自身免疫性疾病的比较。
Scand J Rheumatol. 2007 Jul-Aug;36(4):291-8. doi: 10.1080/03009740701218717.
4
Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.系统性红斑狼疮中的抗C1q抗体和抗内皮细胞抗体——与疾病活动度及肾脏受累的关系
Clin Rheumatol. 2003 Oct;22(4-5):271-8. doi: 10.1007/s10067-003-0724-3.
5
Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.系统性红斑狼疮中补体介导的免疫复合物溶解
Clin Exp Immunol. 1982 Apr;48(1):37-42.
6
Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus.神经精神性系统性红斑狼疮患者的补体水平及抗C1q自身抗体
Lupus. 2016 Jul;25(8):878-88. doi: 10.1177/0961203316643170.
7
C1q, autoimmunity and apoptosis.C1q、自身免疫与细胞凋亡。
Immunobiology. 2002 Sep;205(4-5):395-406. doi: 10.1078/0171-2985-00141.
8
Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.使用单克隆抗C1q和抗C3d抗体的新型酶联免疫吸附测定试剂盒所检测的循环免疫复合物水平与系统性红斑狼疮的临床活动相关,但与类风湿性关节炎的临床活动无关。
J Clin Lab Immunol. 1992;38(4):161-73.
9
Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?系统性红斑狼疮患者血小板上 C1q、C4 和 C3 的沉积增加——与静脉血栓形成有关?
Lupus. 2012 Nov;21(13):1423-32. doi: 10.1177/0961203312457210. Epub 2012 Aug 9.
10
C1q and systemic lupus erythematosus.补体C1q与系统性红斑狼疮
Immunobiology. 1998 Aug;199(2):265-85. doi: 10.1016/S0171-2985(98)80032-6.